| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | $19.28B | $18.56B | $18.21B | $16.31B | $13.56B |
| Cost of Revenue | $13.40B | $12.97B | $12.71B | $11.00B | $8.83B |
| Gross Profit | $5.87B | $5.59B | $5.50B | $5.32B | $4.73B |
| Operating Expenses | $1.80B | $1.75B | $1.68B | $1.56B | $1.41B |
| R&D | $153.00M | $135.00M | $129.00M | $124.00M | $127.00M |
| SG&A | $903.00M | $911.00M | $902.00M | $868.00M | $784.00M |
| Operating Income | $4.07B | $3.83B | $3.83B | $3.75B | $3.33B |
| Interest Expense | $49.00M | $56.00M | $35.00M | $27.00M | $26.00M |
| Tax Expense | $1.28B | $1.18B | $1.14B | $1.07B | $973.00M |
| Net Income | $3.16B | $3.17B | $2.98B | $2.97B | $2.62B |
| EPS (basic) | 0.7600 | 0.7700 | 0.7100 | 0.7000 | 0.6200 |
| EPS (diluted) | 0.7600 | 0.7600 | 0.7100 | 0.7000 | 0.6100 |
| Shares (diluted) | $4.15B | $4.14B | $4.19B | $4.22B | $4.25B |